HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy.

AbstractOBJECTIVE:
To evaluate the stage- and grade-specific survival rate in patients with upper urinary tract (UUT) transitional cell carcinoma (TCC) after open (ONU) or hand-assisted laparoscopic nephroureterectomy (LNU) with bladder-cuff excision.
PATIENTS AND METHODS:
From January 1998 to April 2005, 143 patients with UUT-TCC were treated with either ONU or LNU and enrolled in the study. The peri-operative data were collected by retrospective chart review. The recurrence, metastasis and survival rate were calculated.
RESULTS:
The 5-year disease-specific survival of patients with pT1 disease was 88.1% after ONU and 92.0% after LNU (P = 0.745); the respective values for patients with pT2 were 11/17 and 12/15 (P = 0.874), and for pT3 were six/11 and 12/15 (P = 0.476). The incidence of bladder recurrence within 2 years after surgery was 24.7% for ONU and 19.7% for LNU (P = 0.475).
CONCLUSION:
The results were similar after ONU or LNU with bladder-cuff excision; bladder-cuff excision using a hand-assisted device is effective and serves as a treatment option for patients with UUT-TCC.
AuthorsThomas Y Hsueh, Yi-Hsiu Huang, Allen W Chiu, Steven K Huan, Ying-Huei Lee
JournalBJU international (BJU Int) Vol. 99 Issue 3 Pg. 632-6 (Mar 2007) ISSN: 1464-4096 [Print] England
PMID17166239 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Topics
  • Aged
  • Carcinoma, Transitional Cell (mortality, surgery)
  • Disease-Free Survival
  • Female
  • Humans
  • Laparoscopy (mortality, standards)
  • Male
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Nephrectomy (methods, mortality, standards)
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Ureter (surgery)
  • Urologic Neoplasms (mortality, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: